Login
Toggle navigation
Videos
Categories
Trending
FIRST Shares Norway, positions | Erik Haugland, CEO, First Fondene ASAS OF 30 JUN 2023
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Erik Haugland is the CEO of First Fondene AS
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Fortinova's Key Takeaways: CEO Anders Johansson on Stable Assets and Cash Flow | Anders Johansson, CEO, Fortinova Fastigheter AB.
00:10:00
Despite the "murdering" of our shares, business is good, says Birchcliff CEO | Bruno Geremia, CFO, Birchcliff Energy LtdBIR:TOR
00:10:00
Deepinder Goyal: The Man Behind Zomato’s Success Shares His Transformative Journey | Deepinder Goyal, CEO , Zomato Ltd.
00:10:00
Interview of CEO of Ailleron Company | Rafał Styczeń, CEO, Ailleron SAALL:WSE
00:10:00
Revolutionizing Aerial Application with AgNav's Precision GPS Guidance Systems.
00:10:00
Excelling in West African Gold Mining: The Yaramoko Goldmine Story
00:10:00
Fred Ernest Discusses Vista Gold's Mount Todd Project and Staged Development Strategy
00:10:00
Carlsson Noren Macro Fund: Avkastning genom rörelser på räntemarknaden
00:10:00
"Addressing the Surge in Student Unemployment in Canada: Brendan Caldwell's Analysis"
00:10:00
Michael Schwebel, Manager of Sustainability Consulting at NRG Energy, outlines initiatives addressing sustainability challenges.
00:10:00
Opening Up New Prospects: Datalex & IATA Webinars on NDC's Revolution of Travel Agencies and Airlines | Jonathan Rockett , CEO, Datalex PLCDLE:ISE
00:10:00
Sondrel (Holdings) PLC presents its investor update, while the CEO of Teleperformance cautions that AI lacks common sense in decision-making.